UBS AG - OCULUS INNOVATIVE SCIENCES I ownership

OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 17 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of OCULUS INNOVATIVE SCIENCES I
ValueSharesWeighting
Q3 2014$5,000
-70.6%
1,930
-64.3%
0.00%
Q2 2014$17,000
+142.9%
5,408
+205.4%
0.00%
Q1 2014$7,000
+16.7%
1,771
-2.0%
0.00%
Q4 2013$6,000
-40.0%
1,807
-49.6%
0.00%
Q3 2013$10,000
+66.7%
3,583
+61.5%
0.00%
Q2 2013$6,0002,2190.00%
Other shareholders
OCULUS INNOVATIVE SCIENCES I shareholders Q3 2014
NameSharesValueWeighting ↓
B. Riley Wealth Advisors, Inc. 117,206$276,0000.04%
Madden Advisory Services, Inc. 475$1,0000.00%
UBS AG 1,930$5,0000.00%
DIMENSIONAL FUND ADVISORS LP 3,270$8,0000.00%
BANK OF AMERICA CORP /DE/ 4,225$10,0000.00%
WELLS FARGO & COMPANY/MN 6,371$15,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 24,497$57,0000.00%
AMERIPRISE FINANCIAL INC 142$00.00%
CITIGROUP INC 326$00.00%
MORGAN STANLEY 3,237$8,0000.00%
View complete list of OCULUS INNOVATIVE SCIENCES I shareholders